American Century Companies Inc Kymera Therapeutics, Inc. Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 9,298 shares of KYMR stock, worth $390,144. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,298

Previous 10,847 14.28%

Holding current value

$390,144

Previous $323,000 36.22%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$30.16 - $52.4 $46,717 - $81,167	-1,549 Reduced 14.28%	9,298 $440,000
Q2 2024 Aug 07, 2024	SELL	$29.85 - $39.42 $1.1 Million - $1.45 Million	-36,820 Reduced 77.24%	10,847 $323,000
Q1 2024 May 14, 2024	BUY	$22.9 - $43.57 $570,049 - $1.08 Million	24,893 Added 109.3%	47,667 $1.92 Million
Q4 2023 Feb 13, 2024	BUY	$10.97 - $26.84 $249,830 - $611,254	22,774 New	22,774 $579,000
Q3 2023 Nov 13, 2023	BUY	$13.9 - $23.88 $1.72 Million - $2.96 Million	124,005 Added 112.17%	234,558 $3.26 Million
Q2 2023 Aug 14, 2023	SELL	$22.4 - $34.92 $100,553 - $156,755	-4,489 Reduced 3.9%	110,553 $2.54 Million
Q1 2023 May 11, 2023	BUY	$24.84 - $38.75 $107,507 - $167,710	4,328 Added 3.91%	115,042 $3.41 Million
Q4 2022 Feb 13, 2023	SELL	$19.57 - $30.92 $2.3 Million - $3.63 Million	-117,496 Reduced 51.49%	110,714 $2.76 Million
Q3 2022 Nov 14, 2022	BUY	$20.91 - $34.27 $28,249 - $46,298	1,351 Added 0.6%	228,210 $4.97 Million
Q2 2022 Aug 12, 2022	BUY	$14.13 - $42.55 $196,392 - $591,402	13,899 Added 6.53%	226,859 $4.47 Million
Q1 2022 May 11, 2022	BUY	$35.3 - $64.68 $915,434 - $1.68 Million	25,933 Added 13.87%	212,960 $9.01 Million
Q4 2021 Feb 07, 2022	BUY	$49.91 - $65.56 $1.81 Million - $2.38 Million	36,281 Added 24.07%	187,027 $11.9 Million
Q3 2021 Nov 10, 2021	BUY	$47.8 - $66.66 $2,485 - $3,466	52 Added 0.03%	150,746 $8.86 Million
Q2 2021 Aug 05, 2021	BUY	$31.08 - $51.95 $11,250 - $18,805	362 Added 0.24%	150,694 $7.31 Million
Q1 2021 May 14, 2021	SELL	$35.64 - $85.46 $44,300 - $106,226	-1,243 Reduced 0.82%	150,332 $5.84 Million
Q4 2020 Feb 12, 2021	SELL	$28.07 - $87.83 $5,557 - $17,390	-198 Reduced 0.13%	151,575 $9.4 Million
Q3 2020 Nov 13, 2020	BUY	$26.1 - $33.28 $3.96 Million - $5.05 Million	151,773 New	151,773 $4.9 Million

Others Institutions Holding KYMR

# of Institutions

184

Shares Held

64.4M

Call Options Held

50.6K

Put Options Held

81.7K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.3B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Kymera Therapeutics, Inc. Transaction History